Adam Mostafa
Director of Finance/CFO chez X4 PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
Adam S.
Mostafa is currently the Managing Director at Cumberland Pharmaceuticals, Inc., the Director at Precision Biologics, Inc., and the Director at Satellos Bioscience, Inc. He also serves as the Chief Financial Officer, Secretary & Treasurer at X4 Pharmaceuticals, Inc. starting in 2022.
Previously, he worked as the Managing Director at Cantor Fitzgerald & Co. from 2015 to 2016, an Associate at AQR Capital Management LLC from 2003 to 2007, the Chief Financial Officer at Abpro Corp.
from 2016 to 2018, and the Vice President-Investment Banking Group at CRT Capital Group LLC from 2007 to 2011.
He also held positions at Arsanis, Inc. and Salomon Smith Barney International Ltd.
Mr. Mostafa obtained his undergraduate degree from Brown University in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
-.--% | 11/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
SATELLOS BIOSCIENCE INC
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Adam Mostafa
| Sociétés | Poste | Début |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/03/2019 |
| CUMBERLAND PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
| SATELLOS BIOSCIENCE INC. | Director/Board Member | 05/12/2021 |
Precision Biologics, Inc.
 Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Director/Board Member | - |
Anciens postes connus de Adam Mostafa
| Sociétés | Poste | Fin |
|---|---|---|
| ABPRO CORPORATION | Director of Finance/CFO | 01/08/2018 |
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Corporate Officer/Principal | 01/05/2016 |
CRT Capital Group LLC
 CRT Capital Group LLC Investment Banks/BrokersFinance Founded in 1989, CRT Capital Group LLC is an institutional securities research and brokerage firm located in Stamford, Connecticut. The firm focuses on high-yield and convertible debt, capital structure arbitrage, mergers and acquisitions, special situations and distressed securities. CRT trades senior and subordinated bonds, bank debt, trade claims, convertible bonds, equities, real estate loans, tax exempt securities and private placements. | Corporate Officer/Principal | 01/05/2011 |
AQR Capital Management LLC
 AQR Capital Management LLC Investment ManagersFinance AQR Capital Management LLC (AQR) is a SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. They are a wholly-owned subsidiary of AQR Capital Management Holdings LLC and their ultimate parent is AQR Capital Management Group LP. The firm was founded by Clifford Asness, David Kabiller, and John Liew in 1998. AQR provides investment management services to institutional clients through managed accounts. Their investors may include investment companies, pooled investment vehicles, pension and profit sharing plans, charitable organizations, state or municipal government entities, other investment advisers, insurance companies, sovereign wealth funds and foreign official institutions, corporations or other businesses entities. | Corporate Officer/Principal | 01/03/2007 |
| Salomon Smith Barney International Ltd. | Corporate Officer/Principal | - |
Formation de Adam Mostafa
| Brown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CUMBERLAND PHARMACEUTICALS INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| SATELLOS BIOSCIENCE INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Finance |
AQR Capital Management LLC
AQR Capital Management LLC Investment ManagersFinance AQR Capital Management LLC (AQR) is a SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. They are a wholly-owned subsidiary of AQR Capital Management Holdings LLC and their ultimate parent is AQR Capital Management Group LP. The firm was founded by Clifford Asness, David Kabiller, and John Liew in 1998. AQR provides investment management services to institutional clients through managed accounts. Their investors may include investment companies, pooled investment vehicles, pension and profit sharing plans, charitable organizations, state or municipal government entities, other investment advisers, insurance companies, sovereign wealth funds and foreign official institutions, corporations or other businesses entities. | Finance |
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Precision Biologics, Inc.
Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Retail Trade |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
CRT Capital Group LLC
CRT Capital Group LLC Investment Banks/BrokersFinance Founded in 1989, CRT Capital Group LLC is an institutional securities research and brokerage firm located in Stamford, Connecticut. The firm focuses on high-yield and convertible debt, capital structure arbitrage, mergers and acquisitions, special situations and distressed securities. CRT trades senior and subordinated bonds, bank debt, trade claims, convertible bonds, equities, real estate loans, tax exempt securities and private placements. | Finance |
| Salomon Smith Barney International Ltd. | Finance |
